KaliVir Immunotherapeutics

0 followers


KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells

Industries

Employees

51-200

Links


Org chart

Helena Chaye
Chief Executive Officer

Helena Chaye

Collapse
Stephen H. Thorne
Chief Scientific Officer
James M. Burke
Chief Medical Officer
Adina Pelusio
Chief Development Officer (cdo)

Board & advisors

Kurt Rote
Director
Greg Delgoffe
Scientific Advisor
Lisa Butterfield
Scientific Advisor
Tullia Bruno
Scientific Advisor
Jorge Nieva
Clinical Advisor
Jonathan Rosenberg
Clinical Advisor
Dmitriy Zamarin
Clinical Advisor
Mitesh Borad
Clinical Advisor